HR 4190 · 111th Congress 2009–2011, ended

Endocrine Disruption Prevention Act of 2009

Latest action · Dec 7, 2009 Referred to the Subcommittee on Health.

Progress

Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.

  1. IntroducedDec 3, 2009
  2. Passed HouseNot reached
  3. Passed SenateNot reached
  4. To the PresidentNot reached
  5. Became lawNot reached

Summary

Endocrine Disruption Prevention Act of 2009 - Amends the Public Health Service Act to require the Director of the National Institute of Environmental Health Sciences to establish the Endocrine Disruption Prevention Program, under which the Director shall: (1) conduct and support multidisciplinary research to improve the understanding of endocrine disruption; and (2) conduct workshops and fora on health effects associated with environmental agents that may affect the endocrine system.

Requires the Director to establish an Endocrine Disruption Program Panel, which shall: (1) provide advice to the Director on the conduct and support of research; (2) evaluate existing population-level biomonitoring and biobanking surveillance and research programs and recommend changes needed to develop data on human exposures and effects to support the Program; and (3) develop a list of chemicals of concern for endocrine disruption effects and make findings with respect to such chemicals. Authorizes individuals to petition the Panel to determine whether a chemical should be listed or to revise a finding or determination based on new information.

Requires the Director, if the Panel finds that data are sufficient to determine that there is at least a minimal level of concern associated with a chemical's potential to disrupt the human endocrine system, to transmit the finding, including the routes and sources of exposure to the chemical, to each federal agency with authority to regulate the chemical. Requires each federal agency that receives such a transmission: (1) to reply to the Director describing the agency's regulatory authority, past actions in connection with the chemical, and proposed action to protect human health from the potential endocrine disruption effects of exposure to the chemical; and (2) within one year, to report on the actions taken and future actions proposed by the Agency in response to the Panel's finding.

Requires the Director to establish a program to support graduate and postdoctoral training in fields related to the prevention of endocrine disruption.

Cosponsors 18

Members who signed on, in the order they did. Signatures ran from Dec 3, 2009 to Jul 14, 2010; 7 are original cosponsors, there from the day it was introduced.

SeatCosponsorSigned on
D-MNBetty McCollumOriginalDec 3, 2009
D-CAGeorge MillerOriginalDec 3, 2009
D-MAJames P. McGovernOriginalDec 3, 2009
D-NYMaurice D. HincheyOriginalDec 3, 2009
D-NYNita M. LoweyOriginalDec 3, 2009
D-RIPatrick J. KennedyOriginalDec 3, 2009
D-AZRaúl M. GrijalvaOriginalDec 3, 2009
D-NYLouise McIntosh SlaughterDec 9, 2009
D-ILJanice D. SchakowskyJan 12, 2010
D-DCEleanor Holmes NortonJan 21, 2010
D-MEChellie PingreeJan 27, 2010
D-NYSteve IsraelJan 27, 2010
D-CALois CappsMar 2, 2010
D-CALaura RichardsonMay 24, 2010
D-NHPaul W. HodesJun 14, 2010

Committees 1

Where it was sent and what each committee and subcommittee did with it, in order.

ChamberCommitteeWhat it did
HouseEnergy and Commerce Committee
Referred Dec 3, 2009
Health Subcommittee
Referred Dec 7, 2009

Actions 4

Everything that happened, newest first.

  1. Dec 7, 2009Referred to the Subcommittee on Health.
  2. Dec 3, 2009Introduced in House
  3. Dec 3, 2009Sponsor introductory remarks on measure. (CR E2885)
  4. Dec 3, 2009Referred to the House Committee on Energy and Commerce.

In the Congressional Record 1

Days the Record’s own index lists this bill, newest first, with the pages and the members it names. Pages starting H are the House, S the Senate, E Extensions of Remarks.

WhereIn the RecordMembersDate
ExtensionsDebate and remarks E2885James P. Moran D-VADec 3, 2009

Related bills 1

Companion bills and other measures the record links to this one.

BillTitleRelationshipLatest action
S 2828Endocrine Disruption Prevention Act of 2009Identical billDec 3, 2009

Titles 2

Every title it has carried, official and short, at each stage.

Official Title as Introduced
To amend the Public Health Service Act to authorize the National Institute of Environmental Health Sciences to conduct a research program on endocrine disruption, to prevent and reduce the production of, and exposure to, chemicals that can undermine the development of children before they are born and cause lifelong impairment to their health and function, and for other purposes.
Short Titles as Introduced
Endocrine Disruption Prevention Act of 2009

Subjects

Assigned by the Library of Congress. Policy area: Health.

Text 1

Each version as it was printed, newest first.

  1. Dec 3, 2009Introduced in House

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details.

Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.